SONOVA (OTCMKTS:SONVY - Get Free Report) was upgraded by equities research analysts at Zacks Research from a "strong sell" rating to a "hold" rating in a research note issued to investors on Thursday,Zacks.com reports.
SONVY has been the topic of a number of other reports. Sanford C. Bernstein raised shares of SONOVA from a "hold" rating to a "strong-buy" rating in a research note on Friday, July 18th. Hsbc Global Res cut shares of SONOVA from a "strong-buy" rating to a "hold" rating in a report on Wednesday, May 21st. BNP Paribas cut shares of SONOVA from a "strong-buy" rating to a "strong sell" rating in a report on Wednesday, June 11th. HSBC cut shares of SONOVA from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st. Finally, Kepler Capital Markets upgraded shares of SONOVA from a "strong sell" rating to a "hold" rating in a report on Friday, June 6th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Reduce".
Check Out Our Latest Analysis on SONOVA
SONOVA Stock Performance
Shares of SONOVA stock traded down $1.28 on Thursday, reaching $57.08. The company had a trading volume of 43,750 shares, compared to its average volume of 21,900. The firm's 50 day moving average price is $57.47 and its two-hundred day moving average price is $60.03. SONOVA has a 52-week low of $52.83 and a 52-week high of $77.56. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.27 and a quick ratio of 0.96.
SONOVA Company Profile
(
Get Free Report)
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Featured Articles

Before you consider Sonova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.
While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.